, Phospholipase Action of Platelet-activating Factor Acetylhydrolase, but Not Paraoxonase-1, on Long Fatty Acyl Chain Phospholipid Hydroperoxides, Journal of Biological Chemistry, vol.282, issue.1, pp.100-108, 2007.
DOI : 10.1074/jbc.M608135200
, Platelet-activating Factor Acetylhydrolase, and Not Paraoxonase-1, Is the Oxidized Phospholipid Hydrolase of High Density Lipoprotein Particles, Journal of Biological Chemistry, vol.278, issue.6, pp.3937-3947, 2003.
DOI : 10.1074/jbc.M211126200
, Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite, Free Radical Biology and Medicine, vol.38, issue.2, pp.164-174, 2005.
DOI : 10.1016/j.freeradbiomed.2004.10.010
, Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor-Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E-Deficient Mice, Circulation, vol.103, issue.20, pp.2495-2500, 2001.
DOI : 10.1161/01.CIR.103.20.2495
, HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.12, pp.2169-2175, 2009.
DOI : 10.1161/ATVBAHA.109.194555
, Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein, J Lipid Res, vol.36, pp.2017-2026, 1995.
, Translocation as a means of disseminating lipid hydroperoxide-induced oxidative damage and effector action, Free Radical Biology and Medicine, vol.44, issue.6, pp.956-968, 2008.
DOI : 10.1016/j.freeradbiomed.2007.12.004
, On the ability of high density lipoproteins to remove phospholipid peroxidation products from erythrocyte membranes, Biochemistry (Moscow), vol.66, issue.3, pp.300-304, 2001.
DOI : 10.1023/A:1010203930470
, Copper-induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1635, issue.1, pp.48-54, 2003.
DOI : 10.1016/j.bbalip.2003.10.005
, Protective Effect of Paraoxonase Activity in High-Density Lipoproteins against Erythrocyte Membranes Peroxidation: A Comparison between Healthy Subjects and Type 1 Diabetic Patients, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2957-2962, 2004.
DOI : 10.1210/jc.2003-031897
, High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors., Proceedings of the National Academy of Sciences, vol.89, issue.21, pp.10316-10320, 1992.
DOI : 10.1073/pnas.89.21.10316
, HDL is the major lipoprotein carrier of plasma F2-isoprostanes, The Journal of Lipid Research, vol.50, issue.4, pp.716-722, 2009.
DOI : 10.1194/jlr.M800607-JLR200
, Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein, Atherosclerosis, vol.135, issue.2, pp.193-204, 1997.
DOI : 10.1016/S0021-9150(97)00162-7
, Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation
, Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis, Nature, vol.394, pp.284-287, 1998.
, Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.6, pp.870-876, 2009.
DOI : 10.1161/ATVBAHA.109.186031
, Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.8, pp.1843-1849, 2007.
DOI : 10.1161/ATVBAHA.107.145672
URL : https://hal.archives-ouvertes.fr/inserm-00409657
, Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.10, pp.1881-1888, 2003.
DOI : 10.1161/01.ATV.0000091338.93223.E8
, Small, dense HDL3 particles attenuates apoptosis in endothelial cells: Pivotal role of apolipoprotein A-I, Journal of Cellular and Molecular Medicine, vol.14, pp.608-620, 2010.
DOI : 10.1111/j.1582-4934.2009.00713.x
URL : https://hal.archives-ouvertes.fr/inserm-00410382
, Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events, JAMA, vol.285, issue.12, pp.1585-1591, 2001.
DOI : 10.1001/jama.285.12.1585
, Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma, J Lipid Res, vol.39, pp.1133-1140, 1998.
, Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.10, pp.4963-4971, 2004.
DOI : 10.1210/jc.2004-0305
, A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity, Atherosclerosis, vol.182, issue.2, pp.277-285, 2005.
DOI : 10.1016/j.atherosclerosis.2005.03.001
, Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia, Diabetologia, vol.290, issue.3, pp.529-538, 2005.
DOI : 10.1007/s00125-004-1655-5
, Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.9, pp.2226-2233, 1999.
DOI : 10.1161/01.ATV.19.9.2226
, Antioxidative Activity of HDL Particle Subspecies Is Impaired in Hyperalphalipoproteinemia: Relevance of Enzymatic and Physicochemical Properties, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.3, pp.526-533, 2004.
DOI : 10.1161/01.ATV.0000118276.87061.00
, Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins, Atherosclerosis, vol.204, issue.2, pp.424-428, 2009.
DOI : 10.1016/j.atherosclerosis.2008.07.047
, Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function, Clinica Chimica Acta, vol.359, issue.1-2, pp.171-178, 2005.
DOI : 10.1016/j.cccn.2005.03.050
, Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation, The Journal of Lipid Research, vol.48, issue.6, pp.1396-1401, 2007.
DOI : 10.1194/jlr.M600309-JLR200
, HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation, Diabetologia, vol.108, issue.1, pp.2384-2387, 2007.
DOI : 10.1007/s00125-007-0808-8
, Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation, Diabetologia, vol.42, issue.Suppl 2, pp.1380-1386, 2006.
DOI : 10.1007/s00125-006-0244-1
, The Role of High-Density Lipoproteins in Oxidation and Inflammation, Trends in Cardiovascular Medicine, vol.11, issue.3-4, pp.3-4155, 2001.
DOI : 10.1016/S1050-1738(01)00095-0
, Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome, Circulation, vol.118, issue.12, pp.1259-1267, 2008.
DOI : 10.1161/CIRCULATIONAHA.108.770669
, Increased methionine sulfoxide content of apoA-I in type 1 diabetes, The Journal of Lipid Research, vol.49, issue.4, pp.847-855, 2008.
DOI : 10.1194/jlr.M800015-JLR200